TCL Archive Contract Authority Expiration Confuses NCI Money Bill Estimates, Which Range From $605 To $650 Million June 21, 1974
TCL Archive Learning From Europeans, U.S. Oncologists Consider Role For Oxaliplatin, 5-FU Infusion May 31, 2002
TCL Archive Trial In Metastatic Disease To Be Unblinded After Regorafenib Meets Primary Endpoint November 25, 2011
TCL Archive Darbepoetin Didn’t Decrease Blood Transfusions, Lowered Overall Survival, Study Finds April 27, 2007
TCL Archive In Brief: JNCI Article Describes Advances Pancreatic Cancer; Preventative Oncology Society Formed August 13, 1976
